BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32284011)

  • 1. Liquid biopsy for the detection of clinical biomarkers in early breast cancer: new insights and challenges.
    Matsutani A; Udagawa C; Matsunaga Y; Nakamura S; Zembutsu H
    Pharmacogenomics; 2020 Apr; 21(5):359-367. PubMed ID: 32284011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.
    Croessmann S; Park BH
    Clin Adv Hematol Oncol; 2021 Mar; 19(3):155-161. PubMed ID: 33739964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer.
    Stastny I; Zubor P; Kajo K; Kubatka P; Golubnitschaja O; Dankova Z
    Clin Breast Cancer; 2020 Dec; 20(6):e711-e722. PubMed ID: 32792225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsy Technique May Allow Early Screening.
    Cancer Discov; 2017 Nov; 7(11):1207. PubMed ID: 28903989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
    Eigeliene N; Saarenheimo J; Jekunen A
    Oncology; 2019; 96(3):115-124. PubMed ID: 30654364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection and monitoring of cancer in liquid biopsy: advances and challenges.
    Xue VW; Wong CSC; Cho WCS
    Expert Rev Mol Diagn; 2019 Apr; 19(4):273-276. PubMed ID: 30760042
    [No Abstract]   [Full Text] [Related]  

  • 7. Next-generation sequencing in liquid biopsy: cancer screening and early detection.
    Chen M; Zhao H
    Hum Genomics; 2019 Aug; 13(1):34. PubMed ID: 31370908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and achievements of liquid biopsy technologies employed in early breast cancer.
    Alba-Bernal A; Lavado-Valenzuela R; Domínguez-Recio ME; Jiménez-Rodriguez B; Queipo-Ortuño MI; Alba E; Comino-Méndez I
    EBioMedicine; 2020 Dec; 62():103100. PubMed ID: 33161226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grail to pour $1 billion into blood test to detect early cancer.
    Sheridan C
    Nat Biotechnol; 2017 Feb; 35(2):101-102. PubMed ID: 28178244
    [No Abstract]   [Full Text] [Related]  

  • 11. Liquid biopsy for cancer diagnosis and screening - The promise and challenges.
    Thorat MA
    Ann Clin Biochem; 2019 Jul; 56(4):420-423. PubMed ID: 30971101
    [No Abstract]   [Full Text] [Related]  

  • 12. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
    Hu T; Wolfram J; Srivastava S
    Trends Cancer; 2021 Feb; 7(2):122-133. PubMed ID: 33008796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy for cancer screening, diagnosis, and treatment.
    Smania MA
    J Am Assoc Nurse Pract; 2020 Jan; 32(1):5-7. PubMed ID: 31913212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of incipient tumours by screening of circulating plasma DNA: hype or hope?
    Lenaerts L; Tuveri S; Jatsenko T; Amant F; Vermeesch JR
    Acta Clin Belg; 2020 Feb; 75(1):9-18. PubMed ID: 31578135
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
    J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation and breast cancer: A way forward (Review).
    Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancer.
    Chen K; Kang G; Zhao H; Zhang K; Zhang J; Yang F; Wang J
    Expert Rev Mol Diagn; 2019 May; 19(5):419-427. PubMed ID: 30905203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.